Abstract
Novel pyrrole derivatives were discovered as potent agonists of the niacin receptor, GPR109A. During the derivatization, compound 16 was found to be effective both in vitro and in vivo. The compound 16 exhibited a significant reduction of the non-esterified fatty acid in human GPR109A transgenic rats, and the duration of its in vivo efficacy was much longer than niacin.
Keywords:
GPR109A; Lipolysis; Niacin; Non-esterified fatty acid; Pyrrole.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
MeSH terms
-
Animals
-
Drug Design
-
Fatty Acids, Nonesterified / metabolism
-
Humans
-
Lipolysis / drug effects
-
Nicotinic Agonists / chemistry*
-
Nicotinic Agonists / metabolism
-
Nicotinic Agonists / pharmacology
-
Pyrroles / chemistry*
-
Pyrroles / metabolism
-
Pyrroles / pharmacology
-
Rats
-
Rats, Transgenic
-
Receptors, G-Protein-Coupled / agonists*
-
Receptors, G-Protein-Coupled / metabolism
-
Structure-Activity Relationship
Substances
-
Fatty Acids, Nonesterified
-
HCAR2 protein, human
-
Nicotinic Agonists
-
Pyrroles
-
Receptors, G-Protein-Coupled